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Objectives: Most individuals experience a relatively long period of sub-clinical psychotic
like symptoms, known as the ultra high risk (UHR) or at risk mental states (ARMS), prior
to a first episode of psychosis. Approximately 95% of individuals who will later develop
psychosis are not referred to specialized clinical services and assessed during the UHR
phase. The study aimed to investigate whether a systematic early detection program,
modeled after the successful early detection of psychosis program TIPS, would improve
the detection of help-seeking UHR individuals. The secondary aim was to examine the
rates and predictors of conversion to psychosis after 2 years.
Method: The overall study design was a prospective (2012–2018), follow- up study
of individuals fulfilling UHR inclusion criteria as assessed by the structural interview
for prodromal syndromes (SIPS). Help-seeking UHR individuals were recruited through
systematic early detection strategies in a Norwegian catchment area and treated in the
public mental health services.
Results: In the study period 141 UHR help-seeking individuals were identified. This
averages an incidence of 7 per 100,000 people per year. The baseline assessment was
completed by 99 of these and the 2 year psychosis conversion rate was 20%. A linear
mixed-model regression analysis found that the significant predictors of conversion were
the course of positive (0.038) and negative symptoms (0.017). Age was also a significant
predictor and showed an interaction with female gender (<0.000).
Conclusion: We managed to detect a proportion of UHR individuals in the upper range
of the expected prediction by the population statistics and further case enrichment would
improve this rate. Negative symptoms were significant predictors. As a risk factor for
adverse functional outcomes and social marginalization, this could offer opportunities for
earlier psychosocial intervention.
Keywords: ultra high risk, at risk mental state, prodromal, psychosis, schizophrenia, early detection
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INTRODUCTION

of psychosis risk (22). While semi-structured interviews for
psychosis prediction such as the SIPS (7) have an excellent overall
prognostic performance, and the sensitivity is high (95%), the
specificity is low (47%) (23). Thus, UHR criteria are still unable
to correctly predict transition in all individuals who will later
develop psychosis (22). There will always be challenges when
attempting to detect cases of a low incidence illness stemming
from populations with low or moderate risk, or, in this case,
probably with no or few UHR symptoms (24, 25). This limits the
predictive utility of the UHR concept outside clinical samples that
have undergone risk enrichment (1).
The Prevention of Psychosis study (POP) (26) was launched
in 2012 and builds on the 23 years of experience of the TIPS
study (3, 27) in which intensive awareness and information
campaigns were combined with low threshold detection and
assessment. The awareness and information campaigns were key
to the success of TIPS (2). In POP, the original psychosis specific
information campaigns were adapted to encompass a broader
range of symptoms and psychological distress consistent with the
UHR criteria.

The onset of psychosis can be devastating and typically
occurs in late adolescence or early adulthood (1). This is a
critical developmental stage for relationships, education and
employment, and illness onset can threaten the potential
for a productive, inclusive, and fulfilling adult life. Early
detection programs such as the Scandinavian early treatment
and intervention in psychosis (TIPS) study have endeavored
to improve long term outcomes associated with psychosis by
detecting and intervening early in the course of illness (2, 3).
The TIPS early detection program showed significantly improved
functional outcomes 10 years post diagnosis (4). The success of
such programs has fueled interest in examining the feasibility
of detecting psychosis at an even earlier stage, thereby further
reducing disability (secondary prevention), or even averting
manifestation of psychosis itself (primary prevention) (5, 6).
Prior to a first episode of psychosis (FEP), most individuals
experience an extended period of sub-clinical psychotic-like
symptoms, known as the ultra high risk (UHR) state (7), clinical
high risk for psychosis (CHR-P) (8), or at risk mental state
(ARMS) for psychosis (9). When assessed, a UHR state is usually
defined as meeting criteria for one or more of three syndromes:
the attenuated positive symptoms (APS) syndrome, the brief
limited intermittent psychotic symptoms (BLIPS) syndrome, or
the genetic risk and/or the deterioration (GRD) syndrome (10).
These syndromes are assessed by validated measures, such as the
Comprehensive Assessment of At-Risk Mental States (CAARMS)
(11) or the Structured Interview for Prodromal Syndromes (SIPS)
(7). Moreover, in the fifth version of the Diagnostic and Statistical
Manual of Mental Disorders (DSM 5), APS was included as a
condition for further study (12).
The UHR state is associated with high rates of experienced
trauma, victimization such as bullying, substance use, comorbid
mental disorders, suicidal ideation, and self-harm (1, 8, 13).
While UHR individuals are more likely to be male (58%) (1),
female gender is a predictor of poorer outcomes in terms of
general psychiatric symptoms and functioning at long term
follow up (14). Further, UHR is associated with a 22% risk of
developing a psychotic disorder within 3 years (1). It should also
be noted that the BLIPS syndrome overlaps diagnostically with
the DSM-5 category of brief psychotic episodes (15). Up to 60%
of UHR individuals who do not develop psychosis continue to
display subthreshold psychotic symptoms, or meet criteria for
other mental health disorders (16–18), and impairments in social
functioning are as common as in other mental disorders (1).
Each of the three UHR syndromes includes declining
psychosocial functioning, and often leads to the person seeking
help (19). However, help seeking appears to be delayed with
a recent comprehensive review of 42 meta-analyses reporting
a mean duration of nearly 2 years of APS prior to accessing
specialized services (1). The vast majority of UHR individuals
(95%) are neither referred to UHR services nor assessed during
the UHR phase (20, 21). It is likely that the overall burden
of psychosis risk in secondary mental health care is mostly
unknown. Clinician referrals of UHR individuals to specialized
mental health services depend largely on subjective judgments
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AIMS AND RESEARCH QUESTIONS
The aim of this study was to investigate whether a systematic
early detection program (POP) modeled on the successful early
detection of psychosis program of TIPS (27), would improve the
detection rate of persons at UHR for psychosis. We formulated
the following research questions:
1. What proportion (based on other UHR studies) of the
expected UHR cases can be identified through systematic early
detection strategies?
2. What are the clinical characteristics for a UHR sample over a
2 year follow-up in an early detection program?
3. What are the rates and predictors of 2 year conversion to
psychosis in an early detection program?

DESIGN
The overall study design was a prospective 2 year follow-up study
of UHR individuals. UHR individuals in the catchment area of
Stavanger University Hospital, Norway were recruited through
intensified case detection within secondary mental health clinical
services and in the general population. Consenting participants
received tailored individualized treatment within the secondary
mental health services and structured follow-up assessments.

METHODS
Information Campaigns and Detection
Team
The study used a health service design modeled after the TIPS
study, utilizing the opportunities afforded by the Norwegian
catchment area based public treatment system. In this system,
specialized mental health inpatient and outpatient care serves
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of UHR phase. All out-patient clinics, community mental
health centers, and hospital mental health wards in the
catchment area were annually visited and offered education
on UHR and psychosis assessment and treatment. Newly
employed doctors and psychologists were offered seminars
focusing on SIPS, PANSS, and SCID as part of their
specialist education.

the entire population of the catchment area. Since the mid1990s, Stavanger University Hospital has applied intensive multimodal and multi-level information campaigns to enhance low
threshold access to services for individuals experiencing signs of
FEP in order to reduce the duration of untreated psychosis (DUP)
(2, 3). These have been aimed at the public as well as targeted
groups such as teachers, General practitioners (GP) and primary
care health personnel. The TIPS study included a low threshold
detection team (DT) located in the specialized mental health care
system, for assessing signs of FEP. The launch of the POP study in
2012 changed the content of these information campaigns from
a focus on secondary preventions strategies (DUP reduction) to
a primary prevention strategy aimed at reducing the incidence of
new FEP cases (6). The broad scope of these public mental health
awareness campaigns promotes mental health literacy and can
therefore be considered a combination of a proximal high risk
approach and a population based approach, targeting distal risk
factors for adverse mental health outcomes. The DT was a vital
part of the POP case detection. When the POP study started the
DT combined low-threshold assessment and case identification
of both potential UHR and FEP individuals.
The POP information campaigns used three specific strategies:

Sample
The primary inclusion criterion was meeting one or more of
the following UHR criteria: (1) lifetime Attenuated Positive
Symptoms (APS); (2) lifetime Brief Limited Intermittent
Psychotic Symptoms (BLIPS) or (3) lifetime Genetic Risk and
Deterioration syndrome (GRD). Further inclusion criteria were:
living in the catchment area; aged between 13 and 65 years;
Norwegian or other Scandinavian language speaking; and ability
to provide written informed consent. The exclusion criteria were:
lifetime or current use of antipsychotic medication for more than
4 weeks; any known neurological or endocrine disorders; lifetime
or current occurrence of psychosis and intellectual functioning
below IQ of 70.
The FEP treated incidence rate in the Stavanger University
hospital catchment area, measured by the TIPS studies is 17–
19 per 100,000 people (2, 28, 29). Based on these figures
and the 1-year psychosis conversion risk of 20% (30), we
estimated the yearly incidence of UHR in our catchment area
(∼300,000 inhabitants fulfilling age criteria for inclusion) as 90
per 100,000 people.

A) Targeted information to the general public about mental
health in adolescence, including the early signs of UHR,
where to get help for psychological distress, the importance
of getting help early, and the availability of the low threshold
psychiatric DT. Information was provided through the use
of regular ads in local newspapers, colorful brochures at
General Practitioner (GP) practices, schools, universities,
community health centers, and the like; advertisements
on newspaper web-pages including a link to our website
www.tips-info.com; cinema advertisements before the movie
show, and Facebook advertisements. An example of the
content of the information concerns people were told to be
alert if a person started withdrawing from family, friends or
colleagues. A 2012 quote from a newspaper advertisement
aimed at teenage parents, may serve as an example: “Teenagers
commonly alter behavior during puberty. However, distinct
and sudden behavior changes in teenagers might reasonably
worry parents. Be on guard if a teenager starts self-isolating,
being uncommunicative or depressed.” All advertisements and
information prominently featured contact info for our early
detection team.
B) Targeted education programs for teachers, GPs, and other
workers in community healthcare about mental health in
adolescence, UHR signs and symptoms, and the content and
availability of UHR assessment and treatment. During the
project period all upper secondary schools in the catchment
area were annually visited by members of the DT. A 45 min
lecture was offered to the teachers, focusing on the rationale,
and core elements of the POP study and the availability of lowthreshold UHR assessments. In addition, all GPs in the area
were sent annual newsletters with greetings and thanks around
Christmas and offered site visits and workshops/lectures about
UHR/psychosis and drug abuse.
C) Provision of targeted education for clinicians in the
specialized mental health services about signs and symptoms
Frontiers in Psychiatry | www.frontiersin.org

Recruitment
The study inclusion period was from March 2012 until December
2018. Potential help-seeking UHR individuals in the catchment
area could be referred to the DT by health care providers,
educators, social service agencies, parents, caregivers, or by selfreferral. Potential study participants were screened by telephone
and/or a face-to-face interview and those scoring above a selected
threshold on the Prodromal Questionnaire—Brief (PQ-B) were
then invited for a SIPS interview. The DT recruitment process is
depicted in Figure 1.

Assessment Measures
Prodromal Questionnaire (PQ-Brief)
The PQ- B is a 21-item self report scale with yes or no questions
and was used to screen potential participants. Individuals scoring
above a cut-off > 3 were offered further symptom assessment.
The PQ- B has been established as a reliable and valid screening
tool, with 89% sensitivity and 58% specificity (31).

Structured Interview for Prodromal Syndromes (SIPS)
The SIPS interview assesses positive (5 items), negative (6 items),
disorganized (4 items), and general symptoms (4 items) (7). The
range of the Scale of Psychosis-risk Symptoms (SOPS) is 0–6,
where a score of 0 represents the absence of symptoms, and a
score of 6 represents a severe and psychotic state. APS is the
presence of at least one of the items on the positive symptom
subscale at a moderate (=3), moderately severe (=4), or severe,
but not psychotic level (=5). BLIPS is defined as at least one
positive symptom at the intensity of 6 with a duration of at
3
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FIGURE 1 | Study flow chart and psychosis conversions over time. DT, Detection team, FEP, first episode psychosis, UHR, ultra high risk, POP, prevention of
psychosis; TIPS, early intervention for psychosis study; PANSS, positive and negative syndrome scale; SIPS, structural interview for prodromal syndromes.

Structured Clinical Interview for the Diagnostic and
Statistical Manual-IV. Axis I Disorders (SCID)

least several minutes a day for a frequency of at least once a
month. Finally, criteria for GRD are met when there is a genetic
(familial) risk for any psychosis in the schizophrenia or affective
spectrum plus a deterioration of daily life functioning. Known
family history of psychiatric disorders in first degree relatives was
registered based on clinical interview with participant at baseline.
All SIPS interviews were conducted by one single expert rater,
and interviews were discussed on weekly team meetings in order
to reach consensus. Psychiatric nurses trained in using the SIPS
conducted the SIPS interviews. Consensus regarding the UHR
state was reached during weekly diagnostic meetings. Conversion
to psychosis was defined as scoring 6 or above on one or more of
the items P1–P5 (SOPS) indicating a “Severe and Psychotic” level
of intensity of symptoms. For one participant, due to missing
SIPS data, conversion was ascertained thorough patient medical
file review.

Frontiers in Psychiatry | www.frontiersin.org

The SCID interview (32) was used for diagnostic assessment and
conducted by trained clinical researchers. Reliability of SCID in
the research group was satisfactory at kappa = 0.9 in 2012 (33),
and since then, regular reliability trainings were undertaken to
avoid drift.

Alcohol/Drug Use Disorders Identification Tests
(AUDIT/DUDIT)
Current alcohol abuse was assessed by the Alcohol Use Disorders
Identification Test (AUDIT) (34). The AUDIT is a 10 item
screening instrument, and cut-off score for alcohol misuse was
defined as alcohol use more than three times per week (during
the last 12 months). Current drug abuse was assessed using the
Drug Use Disorders Identification Test (DUDIT). The DUDIT
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The study had ethical approval from the National
Committee for Medical and Health Research Ethics
(2009/949). Participation in the study was based on
written informed consent. Parents or legal guardians
gave informed consent for patients younger than 16 years
of age.

is an 11 item screening instrument, with reported satisfactory
measures of reliability and validity (35–37). The cut-off score for
substance abuse was any use of illegal substances (during the last
12 months).

Calgary Depression Scale for Schizophrenia
Depressive symptoms were assessed by the Calgary Depression
Scale for Schizophrenia (CDSS) (38). The CDSS is a nine item
scale (not present = 0, severe = 3) and the interview and rating
scale are found to have good to high interrater reliability and
validity (39, 40). A score of six or higher indicates probable
depression (40).

Statistics
The statistical analyses were performed in IBM SPSS Statistics
v. 26 (45). Sample characteristics were obtained using simple
descriptive statistics. Bivariate comparisons between those who
converted to psychosis and those who did not were conducted
employing student T-tests for independent samples; distributions
of symptom scores were within the range of “approaching
normality” for positive, negative, and general symptoms
(skewness statistic 0.16; −0.05; and −0.45, respectively) and
moderately skewed for disorganized symptoms (0.85). For
categorical variables with more than one level (i.e., diagnostic
categories), dummy variables were constructed in order to
dichotomise them. For comparing converters to non-converters,
Relative Risk was computed and due to small and uneven
sample sizes, Fisher exact tests were chosen. Linear mixed
model regression was used to estimate longitudinal conversion
predictors. The dependent variable was conversion yes/no, and
predictors (random factors) were SIPS symptom levels the
first 6 months after inclusion in the study. Fixed factors were
assessment time, age, and gender. A 6 months’ time span was
chosen as 70% of the patients who converted did so within
the first 6 months. The model included age and gender and
their interaction. For this analysis, we had access to information
on conversion for 97 participants, and the following symptom
data sets (N’s reported): Baseline 96; 1 month 55; 2 months
55; 3 months 59; 6 months 55. Further, in order to estimate
the association between time to conversion to psychosis, and
symptom levels at identification and study inclusion, a cox
regression model of proportional hazard was fitted. Age, gender,
SIPS symptom levels (mean item scores on positive, negative,
disorganized, and general symptoms), CDSS symptom levels
(total score), and GAF level of symptoms and functioning
were entered as independent (predictor) variables. Covariates
were first entered stepwise, conditional, and then simultaneously
(“enter”). Conversion yes/no was coded as the event for which
the hazard ratio associated with covariates was estimated. Time
to conversion in weeks was entered as the censored time variable.
Regarding missing data for this analysis: Two participants
lacked conversion data, and five lacked baseline symptom data.
Finally, a longitudinal general linear mixed model (GLMM)
of symptom development over time across conversion/nonconversion was fitted. As participants could re-enter the study
after missing one or more assessments, missing assessments
were counted from 1 month to 2 years as part of an attrition
analysis conducted on the whole sample. The analysis compared
participants with <6 missing assessments (over the course of the
2 years) to participants with more than six missing assessments.
No significant differences were identified on baseline age, gender,
or any of the four SIPS scales (sum-scores). Attrition thus appears
to be random.

Global Assessment of Functioning, Split Version
The Global Assessment of Functioning (GAF) split version (41)
was administered at every session.

Assessement Time Points
The SIPS was administered to participants 13 times over 2 years,
starting with baseline, then monthly for 6 months and then
every 3 months until 2 years post baseline. The participants were
diagnostically evaluated by SCID at baseline, 12 and 24 month
along with the other outcome variable interviews.

Follow-Up Clinical Data
Participants who converted to a psychotic disorder during
the study were excluded from the POP study from the
time of conversion and were offered need-adapted treatment
for first episode psychosis and also offered inclusion in the
ongoing FEP study, TIPS 2 (2). We had consent to obtain
clinical data on these participants at the 2 year follow-up
from patient files, regardless of their consent to participate
in TIPS.

UHR Interventions
All study eligible individuals were offered clinical treatment in
the specialized mental health inpatient and outpatient care of
Stavanger University hospital, depending on their age and area
of residence. They were offered individually adapted treatment
containing the following elements: (1) One-to-one monitoring of
clinical status, symptom levels (UHR and psychotic), risk profiles
(suicidality, dangerousness), instrumental and social functioning;
(2) One-to-one case management for clinical, familial, social
and vocational crises, needs and deficits, continuing for as
long as needed; (3) Individual cognitive behavioral therapy
(CBT) (max of 26 sessions, once a week) addressing cognitive
distortions and social impairments, and to maintain real world
investment (based on the EDIE II study) (42); (4) Individuals
were offered single family psycho-education treatment (6–12
months duration) to inform patients and families about current
problems, how to understand and cope with them, especially
within the family (43, 44); (5) Anti-anxiety agents and antidepressants were available if indicated; and (6) Antipsychotic
medication could be offered if the participant either entered
the study with any SIPS positive symptom score of 5, or
if any positive SIPS symptom score(s) moved from a 3 or
4 to a 5.

Frontiers in Psychiatry | www.frontiersin.org
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RESULTS

3.9; significance level of model p < 0.08). The hazard function
is depicted in Figure 3.

Sample Characteristics
In the study period (2012–2018) 4,055 referrals were made to
the DT. After initial screening the DT assessed 1,510 individuals
either by PANSS or SIPS and assigned to the FEP TIPS2 study or
the POP UHR study based on eligibility, (see Figure 1 for details).
In the POP study we identified 141 UHR help-seeking individuals
indicating an incidence of seven per 100,000 people per year. The
baseline assessment was completed by 99 of these individuals.
There were no age or gender differences between consenters and
non-consenters. The mean age of the sample was 16.9 years (SD
= 3.7) and 53% were female and 94% were of Nordic origin.
Being a young sample they had attended school for a mean of
10.5 years (SD = 2.1). The majority (94%) was single and living
with their family. Sixty-six per cent of the participants fulfilled
DSM IV criteria for an affective or anxiety disorder at baseline.
The level of alcohol use was low, with 53% reporting no lifetime
use of alcohol and only one participant reporting alcohol misuse
above cut-off. Fifteen per cent reported illegal drug use during the
12 months prior to baseline.

DISCUSSION
The main finding of this study was that we were able to identify
141 UHR help-seeking individuals, indicating a yearly incidence
of seven per 100,000 people, compared to our prediction of
90 per 100,000 people. It is important to note that despite
the implementation of information campaigns for detection,
our study included help seeking individuals rather than being
restricted to a broad population level campaign. Thus we detected
around 8% of the expected cases compared with 4–5% of
cases reported in a recent meta review (1). It is expected that
the incidence of UHR would be higher in the risk enriched
environment of mental health care compared to the general
community. Even though one of the targeted information
strategies was aimed at providing education for clinicians in the
specialized mental health services on signs and symptoms of the
UHR phase, the study was not able to reach the expected UHR
incidence level. Study findings reflect previous UHR research,
showing a low referral rate of potential UHR individuals to
UHR detection centers, since many individuals are already
being treated in other secondary mental health care services
(20). There is a need for improved tools for case detection
such as the proposed individualized transdiagnostic risk
calculator (21, 22).
Where reducing DUP is achieved through targeted
information about specific symptoms such as hallucinations or
delusions, this is currently not possible in UHR due to the nonspecificity of early emerging symptoms. However, the treatment
provided in our study was not aimed solely at preventing
conversion to psychosis but also at improving psychosocial
functioning and family relations through CBT, psychotherapy
and family work. Medication (anti-anxiety, antidepressants
and antipsychotic medication) was available according to the
treatment algorithm if needed and the clinicians recommended
such use with 47% of the sample reported using such medication
during the 2 year follow up.
Our sample was young, mostly adolescents, with a mean age of
16.9 years whereas a comprehensive review of 42 studies showed
a mean age of UHR/CHR participants of 20.6 years (1). While
we had equal representation of males and females, the review
showed a predominance of males. Depression and anxiety were
the most common mental health problems for our sample as
indicated by diagnostic category and the Calgary Depression
Scale for Schizophrenia (CDSS) scores (40), averaging above
cutoff at baseline.
The 2 year conversion rate of 20% is consistent with
other studies (1, 46). It should be noted that individuals
who developed a FEP were immediately offered treatment for
psychotic symptoms and thus had a DUP of 0 weeks. The
SIPS negative symptoms subscale emerged as the symptom
dimension significantly associated with conversion to psychosis
in all analyses. This warrants some discussion, as conversion
is defined by positive, not negative, symptoms. However, social

Conversion
The 2 year psychosis conversion rate was 19.6 %; that is, 20
participants developed a psychotic disorder, of whom 14 (70%)
converted within 6 months of baseline.
Thus, there was a clear tendency toward early conversion,
with a median time to psychosis of 14 weeks. Table 1 outlines
characteristics of participants who converted vs. non-converters.
Those who converted had significantly higher levels of negative
and general symptoms at baseline. There were no statistically
significant differences between non-converters and converters
in whether they participated in psychotherapy (84 vs. 65%),
family groups (43 vs. 35%), or received medication (45 vs.
60%). Only four participants received second generation antipsychotic medication in low doses, two converters and two nonconverters. Other medication was primarily anti-depressants
(32%) and anxiolytics (5%), with no significant differences on
these medications between converters and non-converters. The
majority of participants (64%) were treated in outpatient clinics
only, and the mean length of hospital inpatient treatment over
the 2 year period was 2.8 weeks (SD = 9.9). At 2 year follow-up,
50% of the converters were clinically remitted and non-psychotic
according to information found in patient files.

Predictors of Conversion
In the longitudinal analyses, employing symptom data over
time in order to predict conversion, the course of positive and
negative symptoms significantly predicted conversion; no other
symptom courses were significant (Table 2). The development of
negative symptoms is illustrated in Figure 2. A higher age also
significantly contributed, and there was an interaction effect with
gender: a higher age in females contributed more to the model
than a higher age in males. In the stepwise cox regression model,
only baseline negative symptom levels were associated with time
to conversion (hazard ratio 2.2; 95% confidence interval 1.2 –

Frontiers in Psychiatry | www.frontiersin.org
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TABLE 1 | Characteristics across 2-year conversion/non-conversion.
Non-conversion (N = 79)

Conversion (N = 20)

Analysis

Mean

SD

Mean

SD

T

Df

P

0.49

Symptoms at baseline
Age

16.5

2.9

17.0

3.0

−0.69

94

SIPS positive

2.1

0.7

2.4

0.7

−0.8

91

0.42

SIPS negative

1.7

0.9

2.4

0.8

−3.1

89

0.03

SIPS disorganized

0.8

0.5

0.9

0.8

−0.5

88

0.62

SIPS general

2.2

0.9

2.6

0.09

−2.0

89

0.05

CDSS total score

7.6

4.9

9.6

4.8

−1.56

92

N

%

N

%

RR

Affective disorder

25

33

8

40

1.1

0.60

Anxiety/OCD

27

35

3

15

0.9

0.11

PTSD

3

4

3

15

1.6

0.10

Developmental disorder

4

6

0

0

0.8

0.58

Schizotypal disorder

1

1

0

0

0.8

1.00

Substance use disorder

1

1

1

5

1.6

0.37

Other

10

13

2

10

0.9

1.00

Psychosis NOS

1

1

2

10

2.4

0.11

Not fulfilling axis 1 criteria

5

7

1

5

1.3

1.00
0.06

0.12
Exact sig. (2-sided)

DSM IV diagnosis at baseline*

Treatment over the 2-year study period
Psychotherapy

65

84

13

65

0.8

Family groups

33

43

7

35

0.9

0.80

Medicationa

35

45

12

60

1.1

0.32

40

52

12

63

1.1

0.45

Gender
Female

Alcohol and substance misuse at baseline
Alcohol

1

1

0

0

0.8

1.00

Illegal substance

12

16

2

11

0.9

1.00

*Missing data N = 3. Significant effects are marked in bold.
or anti-ADHD medication.

a Anti-psychotics:

2 persons who converted and 2 who did not; other medication concerned anti-depressants, anxiolytics

TABLE 2 | Longitudinal predictors of conversion to psychosis.
Variable

Type II sum of squares

df

Mean square

F

Sig

Corrected model

19.18

24

Intercept

0.006

1

0.799

7.40

0.000

0.006

0.055

SIPS positive

0.468

1

0.048

0.816

4.33

0.038

SIPS negative

0.618

1

SIPS disorganized

0.006

1

0.618

5.73

0.017

0.06

0.058

SIPS general

0.03

0.810

1

0.003

0.030

GAF

0.862

0.000

1

0.000

0.004

0.948
0.000

Age

11.317

11

1.029

9.526

Gender

0.014

1

0.014

0.128

0.720

Age*gender

5.621

7

0.752

6.659

0.000

Significant effects are marked in bold. Age*gender interaction term.

romantic involvements (47). Emerging psychological problems
of a severe nature hamper the social functioning essential for
relationships with peers (48). Hence, we argue that when mental

withdrawal is a central feature in negative symptoms. In youth,
healthy psychosocial development commonly occurs in social
arenas, such as school or college, sports clubs, friend groups, and
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FIGURE 2 | Negative symptoms 0–6 months converters/non-converters. Mean item scores and 95% confidence intervals. X-axis: 1 = baseline, 2 = 1 month, 3 = 2
month, 4 = 3 month, 5 = 4 month, 6 = 6 month, 7 = 6 month.

FIGURE 3 | Hazard function of the association between predictors (age, gender, SIPS symptom levels, CDSS symptom levels, GAF symptom and GAF function) and
time to conversion in weeks. X-axis: time in weeks. Y -axis: Cumulative hazard.

STRENGTHS AND LIMITATIONS

health problems reach a level at which the interaction with peers
becomes compromised, this may be indicative of more severe
psychological distress, and in some cases, psychosis.
Finally we are not able to state that the POP early detection
program resulted in an increase in the number of detected
and successfully treated UHR individuals to a level needed to
influence the incidence of FEP, as the treated incidence of FEP
was stable in catchment area across the time-period. This will be
a focus for further studies.

Frontiers in Psychiatry | www.frontiersin.org

Our study capitalized on the strengths of the TIPS longitudinal
cohort study to implement one of the first large scale
information campaigns targeting young people at UHR for
psychosis. Contrary to many other UHR studies, we targeted
both community and clinical populations. Our study provides
important learning for all UHR researchers regarding the process
of recruitment and retention of this young and vulnerable
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population. The primary limitations of our study concern
generalisability and representativeness. A small sample size and a
relatively high attrition rate limit generalisability. Attrition does
however appear to be at random, and the sample can be assumed
to be representative with regard to baseline characteristics.

approvals from the Regional Committees for Medical and
Health Research Ethics, and from the Data Protection Officer at
Stavanger University Hospital, on the basis of specific research
proposals. Requests to access the datasets should be directed
to inge.joa@sus.no.

CONCLUSIONS

ETHICS STATEMENT

In conclusion, the early detection strategies employed were
not able to detect UHR cases to the extent predicted by
the population statistics and further case enrichment appears
to be needed to improve this. Enhanced screening focusing
on subclinical psychotic experiences and social anhedonia
in the adolescent general population might bring more
UHR individuals into clinical services (49, 50). As negative
symptoms were significant predictors of transition to psychosis,
a greater focus on negative or negative-like symptoms and
social withdrawal seems warranted. The use of social media
may to an extent mask social withdrawal, and we thus
propose to expand the use of these platforms in UHR
detection work. Further, we propose combining this with
the use of enhanced screening tools like the individualized
transdiagnostic risk calculator, possibly with an addition of
social withdrawal (21, 22). Finally, we propose that social
media and other awareness campaigns be focused on the
general population, whereas enhanced tools for detection be
used in risk enriched environments, predominantly specialized
adolescent mental health services. This could improve UHR
detection rates and enhance help-seeking behavior in the
target population.
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